Fortfahren mit
Größe auswählen
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
300 mg | Warenkorb auf Verfügbarkeit prüfen | € 364,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
flunixin
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.Cc1c(Nc2ncccc2C(O)=O)cccc1C(F)(F)F
InChI
1S/C14H11F3N2O2.C7H17NO5/c1-8-10(14(15,16)17)5-2-6-11(8)19-12-9(13(20)21)4-3-7-18-12;1-8-2-4(10)6(12)7(13)5(11)3-9/h2-7H,1H3,(H,18,19)(H,20,21);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1
InChI key
MGCCHNLNRBULBU-WZTVWXICSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Flunixin Meglumine Granules
- Flunixin Meglumine Injection
- Flunixin Meglumine Paste
Biochem/physiol Actions
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| manufacturer/tradename USP | manufacturer/tradename EDQM | manufacturer/tradename - | manufacturer/tradename - |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade - | grade certified reference material, pharmaceutical secondary standard |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) - | application(s) pharmaceutical (small molecule) |
| format neat | format neat | format - | format neat |
| API family flunixin | API family flunixin | API family - | API family flunixin |
Still not finding the right product?
Explore all of our products under Flunixinmeglumin
signalword
Warning
hcodes
pcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Lagerklasse
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

